Onderneming Emergent Biosolutions Inc CINNOBER BOAT
Aandelen
0IGA
US29089Q1058
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Commercial Products
47,4
%
| - | - | 497 | 47,4 % | - |
Medical Countermeasures Products
42,6
%
| - | - | 447 | 42,6 % | - |
Services
7,5
%
| - | - | 79 | 7,5 % | - |
Reconciling Items
2,5
%
| 41 | 3,7 % | 26 | 2,5 % | -36,47% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
57,9
%
| 890 | 79,4 % | 607 | 57,9 % | -31,74% |
Canada
21,4
%
| 149 | 13,3 % | 224 | 21,4 % | +50,87% |
Other
20,8
%
| 83 | 7,4 % | 218 | 20,8 % | +163,16% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 21/02 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 26-03-18 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 17-03-23 |
Coleen Glessner
CMP | Compliance Officer | 53 | 01-03-20 |
Laura Kennedy
CMP | Compliance Officer | - | 01-09-16 |
Sharon Solomon
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-17 |
Michelle Pepin
HRO | Human Resources Officer | - | 17-03-23 |
Corporate Officer/Principal | - | - | |
Aubrey Watkins
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | 01-02-09 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 01-04-22 |
Marvin White
BRD | Director/Board Member | 61 | 01-06-10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01-01-05 |
Ronald Richard
BRD | Director/Board Member | 68 | 01-01-05 |
Chairman | 80 | 01-08-04 | |
Neal Fowler
BRD | Director/Board Member | 62 | 28-09-23 |
Sujata Dayal
BRD | Director/Board Member | 61 | 15-07-22 |
Donald DeGolyer
BRD | Director/Board Member | 63 | 28-09-23 |
Kathryn Zoon
BRD | Director/Board Member | 75 | 01-10-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 990 764 | 51 406 736 ( 88,65 %) | 5 600 000 ( 9,657 %) | 88,65 % |
Bedrijfsgegevens
Emergent BioSolutions, Inc.
300 Professional Drive Suite 400
20879, Gaithersburg
+240 631 3200
http://www.emergentbiosolutions.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 681 mld. | |
+21,85% | 556 mld. | |
-4,77% | 361 mld. | |
+16,97% | 325 mld. | |
+5,69% | 285 mld. | |
+13,68% | 235 mld. | |
+3,65% | 199 mld. | |
-11,12% | 189 mld. | |
-3,40% | 157 mld. |